Table1_Case Report: Pulmonary sarcomatoid carcinoma complicating TP53 mutation treated successfully with Tislelizumab combined with Anlotinib—a case report.pdf حسب Yu-Feng Li (136396)

"…Our findings suggest that Tislelizumab combined with Anlotinib may be a preferred strategy in PSC complicating TP53 mutation. Core tip: Immune-check point inhibitors (ICIs) have been reported for the treatment of PSC in a small number of case reports and retrospective analysis, but there are few reports of ICIs combined with anti-angiogenic drugs. …"

Electrochemistry as a Complementary Technique for Revealing the Influence of Reducing Agent Concentration on AgNPs. حسب Sapokazi Timakwe (14127576)

"…This process ended up in the formation of large aggregates that decrease the active surface area and therefore result in a significant decrease in their unique properties. …"